Human Emotion: We Report Our Feelings in 3-D
Says new study in Biological Psychiatry
PHILADELPHIA, Pa., March 26, 2013 /3BL Media/ – Like it or not and despite the surrounding debate of its merits, 3-D is the technology du jour for movie-making in Hollywood. It now turns out that even our brains use 3 dimensions to communicate emotions.
According to a new study published in Biological Psychiatry, the human report of emotion relies on three distinct systems: one system that directs attention to affective states (“I feel”), a second system that categorizes these states into words (“good”, “bad”, etc.); and a third system that relates the intensity of affective responses (“bad” or “awful”?).
Emotions are central to the human experience. Whether we are feeling happy, sad, afraid, or angry, we are often asked to identify and report on these feelings. This happens when friends ask us how we are doing, when we talk about professional or personal relationships, when we meditate, and so on. In fact, the very commonness and ease of reporting what we are feeling can lead us to overlook just how important such reports are - and how devastating the impairment of this ability may be for individuals with clinical disorders ranging from major depression to schizophrenia to autism spectrum disorders.
Progress in brain science has steadily been shedding light on the circuits and processes that underlie mood states. One of the leaders in this effort, Dr. Kevin Ochsner, Director of the Social Cognitive Neuroscience Lab at Columbia University, studies the neural bases of social, cognitive and affective processes. In this new study, he and his team set out to study the processes involved in constructing self-reports of emotion, rather than the effects of the self-reports or the emotional states themselves for which there is already much research.
To accomplish this, they recruited healthy participants who underwent brain scans while completing an experimental task that generated a self-report of emotion. This effort allowed the researchers to examine the neural architecture underlying the emotional reports.
“We find that the seemingly simple ability is supported by three different kinds of brain systems: largely subcortical regions that trigger an initial affective response, parts of medial prefrontal cortex that focus our awareness on the response and help generate possible ways of describing what we are feeling, and a part of the lateral prefrontal cortex that helps pick the best words for the feelings at hand,” said Ochsner.
“These findings suggest that self-reports of emotion - while seemingly simple - are supported by a network of brain regions that together take us from an affecting event to the words that make our feelings known to ourselves and others,” he added. “As such, these results have important implications for understanding both the nature of everyday emotional life - and how the ability to understand and talk about our emotions can break down in clinical populations.”
Dr. John Krystal, Editor of Biological Psychiatry, said, “It is critical that we understand the mechanisms underlying the absorption in emotion, the valence of emotion, and the intensity of emotion. In the short run, appreciation of the distinct circuits mediating these dimensions of emotional experience helps us to understand how brain injury, stroke, and tumors produce different types of mood changes. In the long run, it may help us to better treat mood disorders.”
The article is “The Functional Neural Architecture of Self-Reports of Affective Experience” by Ajay B. Satpute, Jocelyn Shu, Jochen Weber, Mathieu Roy, and Kevin N. Ochsner (doi: 10.1016/j.biopsych.2012.10.001). The article appears in Biological Psychiatry, Volume 73, Issue 7 (April 1, 2013), published by Elsevier.
Notes for Editors
Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Kevin Ochsner at +1 212 854 1860 or ochsner@psych.columbia.edu.
The authors’ affiliations, and disclosures of financial and conflicts of interests are available in the article.
John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.
About Biological Psychiatry
Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.
The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.
Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 129 Psychiatry titles and 16th out of 243 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2011 Impact Factor score for Biological Psychiatry is 8.283.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
